Inclusion matters for people with disabilities and their family and friends. Here's what you can do to join the movement.

Detailed price information for Lexaria Bioscience Corp (LEXX-Q) from The Globe and Mail including charting and trades.

Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing ...

A 9-year-old girl walked slowly down the clinic hallway. 10 months earlier, her days had been dominated by seizures—sudden ...

Our new study highlights a crucial, but often hidden, aspect of child health—the mental health impact of living with two or ...

Medication has long been the cornerstone of treatment for people with epilepsy, but it doesn't stop seizures for everyone and ...

Children with more than one developmental condition – such as ADHD, autism or others – are at risk of depression or anxiety ...

UCB, a global biopharmaceutical company, today announced that the final analysis of an open-label extension (OLE) study with ...

Long-term data on the treatment of children and adults living with Lennox-Gastaut syndrome (LGS) with fenfluramine1 demonstrated sustained reduction in frequency of seizures associated with a fall and ...

Victorian scientists are leading a world-first program that could transform understanding and treatment of a rare genetic ...

Biogen Inc. (Nasdaq: BIIB) and Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine, today ...